Prolonged erythema and hyperpigmentation are frequently encountered side effects of laser skin resurfacing. The author has found intense pulsed light to be effective in the treatment of erythema and hyperpigmentation resulting from laser skin resurfacing in the periorbital area. (Aesthetic Surg J 2002;22:489-491.) L aser-assisted blepharoplasty and periorbital laser skin resurfacing can easily be combined in a single operation to achieve aesthetic improvement of the affected area. 1 However, prolonged erythema and hyperpigmentation are frequent side effects associated with CO 2 laser skin resurfacing. Other less common side effects include acne flares, milia formation, dermatitis, postoperative infection with herpes simplex virus regardless of the patient's history with the virus, hypopigmentation, scarring, and other local or disseminated infections. [2] [3] [4] [5] Erythema almost always occurs after laser treatment and lasts for 2.5 to 4.5 months. It represents the combined effects of epidermal immaturity, reduced melanin absorption of light, reduced dermal optical scattering, and increased blood flow caused by the surgically-induced inflammatory response. 6 Transient hyperpigmentation lasting several months is a complication that occurs in 11.1% to 37% of treated patients. [7] [8] [9] [10] [11] [12] Preoperative treatment of skin with various creams to achieve melanocyte conditioning (eg, hydroquinone regimens) does not seem to reduce the incidence of postoperative hyperpigmentation, possibly because reepithelialization occurring after cutaneous laser resurfacing includes follicular melanocytes that have not been affected by preoperative topical treatment. 13 However, postoperative treatment with topical agents, such as hydroquinone, tretinoin, glycolic acid, L-ascorbic acid, and sunscreens, may be helpful in preventing the occurrence of hyperpigmentation and achieving a faster resolution of erythema. 14, 4, 13 Both intense pulsed light (IPL) sources and nonablative lasers treat pigmented and vascular lesions of various origin effectively. 15, 16 We present 3 cases of periorbital postoperative erythema, hyperpigmentation, and neovascularization (telangiectasias) that were successfully treated by an IPL source. We report on the successful use of one such source, the Photoderm VL/PL (ESC Sharplan, Yoknaem, Israel).
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Treatment Procedure
Before IPL treatments, the patient's skin is cleansed. A cold, clear gel is applied over the area to be treated to protect the epidermis and to act as a coupler for the light emitted by the flashlamp. No local anesthetic cream is used, because Photoderm treatments cause only mild discomfort, and the anesthetic agent's own vasoactive properties could affect the target area. Eye caps are used when necessary. Treatment parameters for discussed cases are provided in the Table. After treatment patients are advised to use soothing hydrating creams and to avoid exposure to sunlight, or at least to use sunscreen creams, for a week or two. A 46-year-old woman with skin type Fitzpatrick IV underwent CO 2 laser skin resurfacing periorbitally. At 4 months after treatment, erythema and hyperpigmentation persisted in spite of a slight improvement achieved by the use of a hydroquinone skin product. Two weeks after an IPL patch test was performed, the affected area was treated. Additional treatments were administered 1 month and 2 months after the first treatment. The erythema and hyperpigmentation resolved completely with no side effects by 2 weeks after the last treatment. A 40-year-old woman with skin type Fitzpatrick III underwent laser-assisted blepharoplasty and periorbital skin resurfacing elsewhere. Erythema, hyperpigmentation, and neovascularization were still evident 2.5 months after treatment (Figure 1, A) . A test spot was performed ( Figure 1, B) , and a series of 3 treatments were administered, with 4-week intervals between treatments to allow the skin to recover from the procedure and to A 44-year-old woman with skin type Fitzpatrick III underwent periorbital CO 2 laser resurfacing 6 months after undergoing a traditional blepharoplasty. After her skin reepithelialized, the patient did not use sunblock cream (in spite of being advised to do so) but instead mis- takenly used an alpha-hydroxy acid regimen at a concentration exceeding her treating physician's instructions. Her erythema persisted, and hyperpigmentation developed 1 month after the patient began using the alphahydroxy acid. A test spot and 3 treatments with Photoderm were administered, with a 4-week interval between treatments. The patient's erythema and hyperpigmentation resolved with no side effects by 3 weeks after the last treatment.
Patient satisfaction and physician's evaluation of the outcome for all 3 cases are presented in Figure 2 .
Erythema and hyperpigmentation are annoying and stressful side effects for patients who undergo CO 2 laser skin resurfacing, even though they tend to resolve spontaneously several months after treatment. To avoid hyperpigmentation and to promote the resolution of erythema, we now administer IPL treatment to every patient who undergoes laser skin resurfacing 1 week after complete skin reepithelialization, when erythema is at an early stage. ■
